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RhoA is one of the more extensively studied members of the
Rho family of small GTPase where it is most readily recognized
for its contributions to actin-myosin contractility and stress
fiber formation. Accordingly, RhoA function during cell
migration has been relegated to the rear of the cell where
it mediates retraction of the trailing edge. However, RhoA
can also mediate membrane ruffling, lamellae formation
and membrane blebbing, thus suggesting an active role in
membrane protrusions at the leading edge. With the advent
of fluorescence resonance energy transfer (FRET)-based
Rho activity reporters, RhoA has been shown to be active
at the leading edge of migrating cells where it precedes
Rac and Cdc42 activation. These observations demonstrate
a remarkable versatility to RhoA signaling, but how RhoA
function can switch between contraction and protrusion has
remained an enigma. This review highlights recent advances
regarding how the cooperation of Rho effector Rhotekin and
S100A4 suppresses stress fiber generation to permit RhoAmediated lamellae formation.

Introduction
Rho family small GTPases mediate multiple aspects of tumor
progression including cell transformation, cytokinesis, angiogenesis, extracellular matrix deposition and tumor cell dissemination. Rho GTPases belong to the Ras superfamily and consist
of more than 20 members of 20–30 KDa GTP-binding proteins
in mammals. Like Ras, Rho GTPases act as molecular switches
by cycling from GTP bound active state to GDP bound inactive state. The cycling between these two states is positively
controlled by guanine nucleotide-exchange factors (GEFs), and
negatively regulated by its intrinsic GTPase activity, GTPase
activating proteins (GAPs) and guanine nucleotide-dissociation
inhibitors (GDIs).1-3 The major function of Rho small GTPases
is the coordination of actin cytoskeleton reorganization in
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response to receptor activation (including growth factor, cytokine and adhesion receptors), which in turn regulates GEF and
GAP activities.3,4
Most notably, the members of the Rho family of small GTPases
are renowned for their contributions to actin cytoskeletal reorganization that drive cell motility and invasion. These concepts
were brought to the forefront based on landmark findings by
Ridley, Hall and colleagues in 1992 when they documented that
Rac stimulated the formation of lamellae5 while RhoA mediated
stress fiber formation.6 In the intervening two decades, our vision
of Rac mediating lamellae formation and its importance to cell
motility remains constant while many of the details of how these
processes are regulated has been elucidated (reviewed in refs. 3
and 4). In contrast, the literature regarding RhoA’s role in the
migration and invasion is more conflicting, perhaps due to the
greater versatility to RhoA functions.
The Rho subgroup of Rho GTPases, including RhoA, RhoB
and RhoC, share about 85% amino acid sequence identity where
the primary differences are found in the C-terminal hypervariable region.3 Given that Rho proteins play important roles in
cell migration, actin cytoskeleton reorganization, and focal
adhesion, it is well accepted that Rho signaling should contribute to tumor invasion and metastasis. Indeed, RhoA and RhoC
have been shown to be involved in different stages of tumor progression such as loss of apical-basal polarity and cell junctions,
intravasation and vascularization.7 There is substantial evidence
to support the involvement of aberrant expression of Rho, especially RhoC in the metastatic capacity of different types of cancers, such as breast, colon, prostate, lung, head and neck and
pancreatic.7,8 In contrast, most studies suggest that RhoB acts as
a tumor suppressor and is generally downregulated in cancers.3,8
RhoA and RhoC are equally capable of mediating stress fiber
formation and generating contractile force needed for retraction
of the trailing edge during migration. However, recent studies utilizing Rho activity biosensors suggest that RhoA is also
activated at the leading edge of the migrating cells9,10 and, thus,
validate several reports that demonstrate that RhoA functions
in membrane ruffling and lamellae formation.9,11-13 Additionally,
RhoA has been implicated in membrane blebbing, which has
been implicated in amoeboid-like motility (reviewed in ref. 14).
In light of these observations, our perceptions of the role of Rho
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Figure 1. RhoA mediated pathways to actin polymerization and actomyosin contractility. RhoA facilitates actin polymerization by positively
regulating multiple effectors and kinases (arrows) as well as through
the negative regulation of cofilin by the ROCK-LIMK pathway (blunted
lines). Through parallel pathways, the RhoA-ROCK pathway also leads to
myosin mediated actin contraction by inhibition of myosin phosphatase or through the direct phosphorylation of MLC.

GTPases in cell migration, tumor cell invasion and metastasis
are changing.
This mini-review focuses on recent studies that shed light on
how conditional signaling can influence the functional output
of RhoA signaling. Specifically, we will discuss the mechanisms
of how RhoA signaling, in conjunction with the Rho effector Rhotekin and the pro-metastatic calcium binding protein
S100A4, can promote membrane protrusions such as lamellipodial ruffles in lieu of stress fibers. We will further discuss
how these RhoA functions associate with cell migration and
invasion in two-dimensional (2D) and three-dimensional (3D)
environments.
RhoA in Cell Migration
The importance of Rho proteins in cell migration and invasion
is now well established; however, it has not always been so. The
role of RhoA in cell migration at one time was considered by
many to be dispensable or inhibitory to cell migration. Several
factors lead to the early conclusion. Primarily the observation
that RhoA promotes stress fibers and strong adhesion through
focal adhesion formation guided the path to this deduction
(reviewed in refs. 4 and 15). There also exists a reciprocal relationship between RhoA and Rac1 in which high Rac activity
leads to the reduction of Rho and vice versa.16,17 Since Rac is
instrumental for lamellae formation and cellular protrusions
it seemed logical that RhoA would be inhibitory to these processes. Finally, the involvement of p190RhoGAP in cell spreading and migration,18 as well as the induction of RhoC in the
metastatic process3 cemented this concept that RhoA might be
detrimental to, or at least dispensable for, cell migration and
invasion.
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However, many studies demonstrating a positive role for
RhoA in migration prompted to the concept that Rac and RhoA
were spatially separated during cell migration such that Rac was
activated at the leading edge and RhoA was activated at the trailing edge.19 With the advent of FRET-based Rho GTPase activity
biosensors, the hypotheses regarding the small GTPases in cell
migration began to evolve. RhoA was found to be active at the
leading edge of migrating cells. Importantly, the three major Rho
small GTPases (Rac1, Cdc42 and RhoA) were all activated at the
front of the migrating cells in a spatial and temporal manner,
such that RhoA activation preceded that of Rac and Cdc42.20,21
These studies added validity to previous studies,9,11,12,22 including
our own,13,23 that implicated RhoA in membrane ruffling and
lamellae formation and, therefore, an important role in the protrusive events at the leading edge that drive cell motility.
How RhoA switches from stress fibers to lamellae formation is
unclear. It is tempting to speculate that the choice of one effector
controls this fate; however, both membrane ruffling and stress
fiber formation are mediated through the Rho effectors ROCK
and mammalian homolog of Drosophila diaphanous (mDia).24
To understand how this switch occurs, we will first discuss what
we know about RhoA effectors and stress fiber formation.
Rho Effectors and Stress Fiber Formation
The effectors of small Rho GTPases comprise of a variety of proteins including lipid kinases, scaffold proteins, and serine/threonine kinases that can be classified into discrete classes based on
how they bind the switch regions of Rho.22,25 Although RhoA,
RhoB and RhoC share overlapping effectors, whether the preference of each isoform for different effectors contributes to distinct
effect on cell behavior has not been fully elucidated. Among these
effectors, however, ROCK and mDia have been most extensively
studied and their role in stress fiber formation well documented.
ROCK is a major mediator of Rho function. Inhibition of
ROCK blocks the formation of most Rho-mediated actin cytoskeletal structures, including stress fibers. ROCK inactivates
myosin phosphatase by phosphorylation of its myosin-binding
subunit as well as direct phosphorylation and activation of myosin light chain. As a consequence, ROCK enhances actomyosin
contractility.22 The resulting contraction on the actin filaments
leads to the bundling of actin fibers and the clustering integrins into focal adhesions.15,26 However, constitutive activation of
ROCK is insufficient to promote stress fiber formation, suggesting that ROCK is necessary but not sufficient. Notably, actin
polymerization is also required. As shown in Figure 1, other
effectors downstream of RhoA including phosphotidylinositide
4P-5 kinase (PI4P-5K) and mDia have been shown to stimulate
actin polymerization.24,27,28 Furthermore, ROCK-mediated phosphorylation and activation of LIM kinase (LIMK) facilitates
actin polymerization by stabilizing actin filaments by inactivating the actin severing functions of cofilin29 (Fig. 1). These observations support the cooperation of ROCK and mDia in stress
fiber formation.
During their formation, stress fibers lead to the generation of
focal adhesions and, in the absence of adequate focal adhesion
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turnover, are associated with non-motile cells. Constitutive activation of RhoA has been demonstrated to negatively regulate
cell migration due to excess stress fiber formation and adhesion
forces.30,31 Inhibition of ROCK under conditions where RhoA
activity is high or altering the ratio of ROCK to mDia can reduce
stress fiber thickness and favor cell migration.15,22 These studies
support the concept that the contractility downstream of RhoA
activity must be tempered in order for membrane protrusions to
dominate. Notably, most advanced carcinomas do not form true
stress fibers, but rather thinner contractile filaments (which are
often referred to as stress fibers for lack of a better term) that
are conducive to cell migration. These observations suggest that
advanced carcinoma cells acquire a mechanism to temper RhoAROCK mediated contractility to permit the protrusive events
downstream to predominate.
RhoA Function at the Leading Edge
The membrane protrusions at the leading edge, including filopodia and lamellae, are well known to be regulated by Cdc42
and Rac, respectively. However, in cells with epithelial origin,
RhoA is active in the leading edge, as shown by using fluorescence-based Rho biosensors,9,10,20 where it promotes membrane
ruffling and facilitates cell motility.9,11-13 In 2000, we were the
first to publish that RhoA could promote the formation of lamellae in the absense of Rac1. We showed that the engagement of
the integrin α6β4 with laminin in Clone A colon carcinoma
cells produced RhoA-dependent membrane ruffles and lamellae
that were instrumental for haptotaxis of these cells.13 While quite
heretical at the time, the concept that RhoA activity can localize
at the leading edge to drive migration was validated using RhoA
biosensors which demonstrated that RhoA activity localized to
the leading edge of fibroblasts. Shortly thereafter, Kurokawa et
al. found that RhoA is not only active in the leading edge but
also in the rear of HeLa cells during random migration on collagen. They further demonstrated that RhoA activity persists in
membrane ruffles upon growth factor stimulation in Cos1 and
NIH3T3 cells and that RhoA activity was required for the induction of membrane ruffles.9
These concepts led to confusion regarding the timing of activation and the relationship among the small GTPases at the leading edge. To answer this question, collaborative efforts between
the Hahn and Danuser labs assessed the activation of RhoA,
Rac1 and Cdc42 in the same cells under growth factor stimulation. They found that the activation of RhoA synchronized with
protrusions, was restricted to within 2 μm of the leading edge,
and preceded the activation of Rac and Cdc42.20 This restriction
and slight separation of Rac and Rho activities from each other
helps to explain how integrin- and Rac-activated GAP activities
could co-exist with RhoA at the leading edge. Furthermore, it
highlights that RhoA activity at the leading edge must be delicately regulated by positive and negative regulators in order for
RhoA to promote membrane protrusions.
How RhoA regulates two very different processes such as
stress fibers and membrane ruffling is puzzling. A mechanism for
switching these two functions must exist. As mentioned above,
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Figure 2. RhoA signaling toward actin polymerization and actomyosin
contractility is delicately balanced. While RhoA signals to actin polymerization as well as myosin-mediated actin filament contraction, tipping
this balance toward more actin polymerization facilitates membrane
ruffling and lamellae formation, while higher contractile forces lead to
stress fiber formation.

altering the ratio of ROCK to mDia can influence these processes.
Additional mechanisms to regulate actin polymerization are present downstream of RhoA (Fig. 2). Notably, adducin phosphorylation by ROCK has been shown to be an instrumental aspect of
the pro-ruffling features of ROCK signaling.11 However, these
effectors offer more of a sliding scale than a discrete switch.
Work from our lab has shown that integrin α6β4 promotes
membrane ruffling and lamellae formation in carcinoma cells,
which are mediated by RhoA.13,23,32 Notably, other reports implicating RhoA in membrane ruffling came from cells of epithelial
origin9,11,12 that also express integrin α6β4. The most dramatic
example of this concept is seen in the MDA-MB-435 cells. In
the absence of integrin α6β4 expression, these cells utilize RhoC
for migration and do not form lamellae in response to LPA.
However, integrin α6β4 signaling facilitates RhoA activation
and RhoA-dependent membrane ruffles and lamellae with LPA
stimulation, which in turn dramatically enhances cell migration
and invasion.23,32 These observations suggest that integrin α6β4
may hold the key to how the function of RhoA is switched from
stress fibers to lamellae formation. Through our transcriptome
studies on integrin α6β4 in breast, we found that integrin α6β4
controls the expression of the pro-metastatic gene S100A4.33 In
the next section, we discuss our recent finding that S100A4 binds
the Rho effector Rhotekin to form a complex with RhoA, which
in turns changes RhoA function to permit this GTPase to stimulate membrane ruffling in lieu of stress fibers.
Rhotekin and S100A4 Navigate the Switch
Rhotekin is a scaffold protein that was initially identified as a putative target for Rho that interacts with both RhoA and RhoC.34
The search for Rhotekin interacting proteins focused on the
C-terminal domain since it contains a consensus binding motif
for Class I PDZ proteins. Rhotekin was found to interact with
vinexin, Lin7B, PIST and septin, which are considered to play
roles in cell polarity, focal adhesion and septin organization.35-37
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Rhotekin was also found to be overexpressed in metastatic colon
cancer38 and gastric adenocarcinoma cells and confers resistance
to apoptosis through activation of NF-κB.39 Further impact on
transcription was shown through the interaction of Rhotekin
and TIP-1 with active Rho which strongly activate SRE (serum
response element).37 A recent study revealed that Rhotekin is a
substrate of Protein kinase D (PKD). Although there is no physical interaction between Rhotekin and PKD, the authors found
that PKD induced Rhotekin phosphorylation at serine 435. This
phosphorylation event significantly increase membrane anchoring of RhoA as well as RhoA activity, thereby promoting actin
stress fiber formation in NIH-3T3 cells.40 Despite these findings, the role of Rhotekin in Rho-mediated downstream signal transduction leading to actin cytoskeleton reorganization
remained largely unknown. This may be because the domain
of Rhotekin that influences the cytoskeleton is the Rho binding domain (RBD). Based on our recent serendipitous finding
that S100A4 can bind the RBD of Rhotekin, we have uncovered
a new function for Rhotekin that may help explain its role in
tumor progression.
S100A4 is a calcium binding EF-hand protein that belongs to
the S100 superfamily that contains at least 21 family members.
It was cloned independently from various cell types under different names including metastasin-1 (mts1), CAPL and fibroblast
specific protein (FSP1), 18A2, pEL98, p9Ka, 42A and calvasculin.41,42 S100A4 is associated with the progression of a variety
of cancers, including breast, prostate, pancreatic, gallbladder,
colon, gastric, lung and melanoma41-44 and has been considered
as a valuable prognostic marker for several tumors including
breast and colon.45,46 The role of S100A4 in tumor progression,
and specifically on tumor metastasis, was also documented in
several types of cancer by experimental metastasis and genetically-modified mouse models.41,42 Although S100A4 was initially
identified as a fibroblast marker,47 investigations on S100A4
expression demonstrated that it is expressed in highly motile
cell types, including T-lymphocytes, neutrophils, macrophages,
platelets, endothelial cells, fibroblast and carcinoma cells.41,42,48
Notably, cell motility has been implicated as a major function
controlled by S100A4.43 Intracellularly, S100A4 interacts with
target proteins such as heavy chain of non-muscle myosin IIA
(MHC-IIA),49 tropomyosin50 and liprin β1.51 Most notably, the
interaction of S100A4 with myosin IIA heavy chain inhibits
myosin IIA phosphorylation, promotes myosin disassembly and
reduces the contractility of myosin; this well-defined feature of
S100A4 represents a major mechanism of how S100A4 mediates
cell motility and invasion.41,52,53
In a recent study from our group,54 we found that S100A4
specifically bound the RBD of Rhotekin, but not the RBDs of
other class I effectors or critical Rho effectors such as ROCK or
mDia. We further determined that S100A4 bound a region of
the RBD distinct from where RhoA bound. This observation
led to the discovery that active RhoA-Rhotekin and S100A4
could form a complex. Despite the proposed role of Rhotekin in
maintaining Rho in an active conformation, we saw no changes
in RhoA activity with Rhotekin and/or S100A4 knockdown
(unpublished observation). Instead, we discovered a functional
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change in RhoA functional output. Using MDA-MB-231 stimulated with EGF as a model, we found that RNAi-mediated
suppression of S100A4 and Rhotekin switched Rho from mediating membrane ruffling and lamellae to thick contractile stress
fibers.
In Figure 3, we depict our working model of this concept of
how S100A4 and Rhotekin cooperate to alter RhoA function.
Central to this concept is the fact that S100A4 binds to the myosin IIA heavy chain to prevent its oligomerization and temper
contractility. As shown in Figure 3A, we propose that when
cells express both Rhotekin and S100A4, growth factor stimulation of Rho activity leads to the coupling of Rho to S100A4.
Under these conditions, myosin II oligomerization is restricted
within close proximity to active Rho, thus limiting stress fiber
formation. The inhibition of myosin-mediated actin contractility then permits membrane ruffling and lamellae formation to
predominate downstream of Rho effectors such as ROCK. In
the absence of S100A4 and Rhotekin, RhoA activation and nonoligomeric myosin do not colocalize, therefore the contractility
events downstream of RhoA signaling predominate leading to
stress fiber formation (Fig. 3B).
Contractility that limits the rate of membrane ruffling and
protrusions occurs beyond the lamellipodium into the lamella
where myosin IIA mediates retrograde actin flow. Notably, the
rate of cellular protrusions is inversely correlated with retrograde
actin flow within lamellae such that blocking myosin IIA by
siRNA or blebbistatin can increase membrane protrusions.55,56 If
the modulation of actomyosin contractility by S100A4 extends
beyond the lamellipodium (where RhoA is localized and signals) into the lamella (where MLCK has been shown to be more
active57), it would suggest that that S100A4 could facilitate RhoA
signaling and membrane protrusion by restricting retrograde
flow within the lamella through the modulation of myosin IIA
contractility regulated by other pathways. However, to determine
if these mechanisms are in fact coupled and coordinated in such
a manner will require further analysis.
RhoA in 3D Invasion
While RhoA has been shown to function in 2D migration systems, there are clearly conditions in which RhoA is dispensable for or inhibitory to cell migration. However, with the use
of more physiological assessments of tumor cell invasion and
3D invasive growth, RhoA becomes much more influential.
The mechanisms governing invasion of carcinoma cells in 3D
and in vivo differ greatly from those in 2D culture. First and
foremost, the tension supplied in 2D cultures comes from the
glass or plastic support on which cells are plated. In 3D cultures
and in vivo, the tension in the matrix must be supplied by the
tumor cells themselves or from nearby stromal cells. Alignment
of the collagen fibers found in the stroma is diagnostic for
tumor aggressiveness58 and has been shown by the Condeelis
and Segall groups to facilitate tumor cell migration along these
filaments in vivo.59 The concept that Rho contributes to tension within the tumor microenvironment has been validated by
Provensano and Keely where they elegantly showed that Rho
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Figure 3. Mechanisms of S100A4-Rhotekin-RhoA crosstalk in mediating membrane ruffling. (A) We propose that S100A4-mediated inhibition of
myosin IIA heavy chain oligomerization limits the contractility of pMLC-myosin IIA complex. Under this condition, the actin polymerization functions
of ROCK (shown here) and other effectors such as mDia (not shown) predominate, thus permitting the formation of lamellae. The lower panel depicts
MDA-MB-231 cells stimulated with EGF for 5 min and then stained with phalloidin. (B) In the absence of S100A4 and Rhotekin, Rho/ROCK-mediated
MLC phosphorylation in the presence of oligomers of myosin IIA facilitates the contractility required for stress fiber formation, while preventing
membrane ruffles downstream of RhoA from forming. The lower panel represents an extreme phenotype of MDA-MB-231 cells with RNAi-mediated
reduction of S100A4 and Rhotekin that were stimulated with EGF for 5 min and then stained with phalloidin.

signaling in this context to be a major contributor to tumor
aggressiveness.60-62
Certainly the role of Rho proteins in 3D invasive growth
is more complex than the tension placed on the extracellular
matrices. In our study,54 we found that simultaneous reduction
of Rhotekin and S100A4 led to the collapse of invasive structures thus limiting cells to the formation of acinar structures in
3D breast carcinoma model. If our hypotheses are correct, cells
without S100A4 and Rhotekin would exert greater tension on
the matrix, yet still do not demonstrate invasive growth. Clearly
the concept of balancing protrusive events and contractility
remains relevant to the 3D environment. Perhaps in the absence
of protrusion-promoting signals, the default is to form tighter
cell:cell adhesion and an acinar structure. To fully understand
the role of Rho proteins in 3D invasive growth and the invasive
process in vivo, our concepts must evolve as we improve our
understanding of how cells interact with their microenvironment under more physiological conditions.
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RhoA Cooperation with Other Small GTPases
There is still much to be deciphered regarding how RhoA promotes membrane ruffling. Despite the abilities of RhoA to stimulate actin polymerization through multiple effectors, it rarely works
alone in this process. In many cell types, either Rac or Cdc42 is
activated in conjunction with RhoA.9,21,23 Both Rac and Cdc42
signal through Pak1 to stimulate LIMK, which then phosphorylates and inactivates cofilin to prevent cleavage of actin fibers. This
represents a convergence point with RhoA-ROCK pathway that
facilitates F-actin polymerization. However, Rac and Cdc42 both
signal through either WAVE or WASP proteins to stimulate the
Arp2/3 complex, a process not recognized as a Rho function, which
may be necessary for actin branching during lamellae formation.
Alternatively, Rac and Cdc42 have been suggested to recruit mDia
to Rho,9 thus facilitating lamellae formation.
The studies to date on Rho in membrane ruffling and lamellae formation have implicated RhoA. However, is it possible
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that RhoA and RhoC could share functions in these processes
or potentially swap roles under select conditions? RhoA and
RhoC share high homology and activate many of the same
effectors, including ROCK, mDia and Rhotekin.22,34 While
the absolute affinities of each of these shared effectors for the
individual GTPases has not been systematically assessed, it is
likely that subtle differences in affinities could affect effector
choice. Alternatively, GTPase localization through its hypervariable region or select activation by specific GEFs could ultimately govern the individual function of the two GTPases.
Considering the evidence for RhoA at the leading edge, it is
possible that RhoA functions in membrane ruffling and lamellae formation while RhoC functions in the cell body to mediate actin cytoskeletal contraction and trailing edge retraction.
However, in a recent study by Anne Ridley’s group, RhoC
was found to specifically bind FMNL3, which may help to
define differences between RhoA and RhoC functions during carcinoma cell migration. In that study, they suggest that
RhoA functions at the leading edge to mediate membrane ruffling while RhoC contracts the base of the lamellae to prevent
lamellae broadening and loss of orientation.63 This study is an
important example of the cooperation of RhoA and RhoC in
cell migration. How RhoA and RhoC parcel out their duties
during tumor invasion and how these functions change in a 3D
environment will require further investigation.

Concluding Remarks
Tumor invasive growth is a complex, multistep program involved
in the interplay of tumor cells and the microenvironment, and
in turn tumor cells acquire the propensity for migration, invasion and proliferation.64 Rho signaling is engaged in at least two
distinct types of motility in three-dimensional matrix, amoeboid
motility and mesenchymal motility.65 Interestingly, these two
types of migration are interchangeable. Beyond this versatility,
we highlight new pathways involving the Rho effector Rhotekin
and the metastasis associated S100A4 that direct Rho signaling
from migration-inhibiting stress fibers to migration- and invasionpromoting lamellipodial ruffles and lamellae. These observations
highlight the amazing dynamics of RhoA signaling, which dramatically impacts how we view RhoA signaling during cancer
invasion and ultimately the metastatic process. Furthermore, these
studies demonstrate how contractility functions of RhoA can be
tempered to favor actin polymerization; and that the protrusive
functions of RhoA are as critical for tumor progression as its
impact on cellular traction, matrix tension, and actin contractility.
Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.
Acknowledgments

This work was funded by NIH R01-CA109136.
References
1.

Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new
insights into their functions from in vivo studies. Nat
Rev Mol Cell Biol 2008; 9:690-701; PMID:18719708;
http://dx.doi.org/10.1038/nrm2476
2. Hall A. Rho GTPases and the actin cytoskeleton.
Science 1998; 279:509-14; PMID:9438836; http://
dx.doi.org/10.1126/science.279.5350.509
3. Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett 2008; 582:2093-101; PMID:18460342;
http://dx.doi.org/10.1016/j.febslet.2008.04.039
4. Hall A. Rho GTPases and the actin cytoskeleton.
Science 1998; 279:509-14; PMID:9438836; http://
dx.doi.org/10.1126/science.279.5350.509
5. Ridley AJ, Paterson HF, Johnston CL, Diekmann D,
Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell
1992; 70:401-10; PMID:1643658; http://dx.doi.
org/10.1016/0092-8674(92)90164-8
6. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions
and actin stress fibers in response to growth factors.
Cell 1992; 70:389-99; PMID:1643657; http://dx.doi.
org/10.1016/0092-8674(92)90163-7
7. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat
Rev Cancer 2002; 2:133-42; PMID:12635176; http://
dx.doi.org/10.1038/nrc725
8. Karlsson R, Pedersen ED, Wang Z, Brakebusch C. Rho
GTPase function in tumorigenesis. Biochim Biophys
Acta 2009; 1796:91-8.
9. Kurokawa K, Matsuda M. Localized RhoA activation as
a requirement for the induction of membrane ruffling.
Mol Biol Cell 2005; 16:4294-303; PMID:15987744;
http://dx.doi.org/10.1091/mbc.E04-12-1076
10. Pertz O, Hodgson L, Klemke RL, Hahn KM.
Spatiotemporal dynamics of RhoA activity in migrating
cells. Nature 2006; 440:1069-72; PMID:16547516;
http://dx.doi.org/10.1038/nature04665

6

11. Fukata Y, Oshiro N, Kinoshita N, Kawano Y, Matsuoka
Y, Bennett V, et al. Phosphorylation of adducin by
Rho-kinase plays a crucial role in cell motility. J
Cell Biol 1999; 145:347-61; PMID:10209029; http://
dx.doi.org/10.1083/jcb.145.2.347
12. Nishiyama T, Sasaki T, Takaishi K, Kato M, Yaku H,
Araki K, et al. rac p21 is involved in insulin-induced
membrane ruffling and rho p21 is involved in hepatocyte growth factor- and 12-0-tetradecanoylphorbol13-acetate (TPA)-induced membrane ruffling in KB
cells. Mol Cell Biol 1994; 14:2247-456; http://dx.doi.
org/10.1128/MCB.14.4.2447
13. O’Connor KL, Nguyen BK, Mercurio AM. RhoA
function in lamellae formation and migration is regulated by the α6β4 integrin and cAMP metabolism. J
Cell Biol 2000; 148:253-8; PMID:10648558; http://
dx.doi.org/10.1083/jcb.148.2.253
14. Charras G, Paluch E. Blebs lead the way: how to
migrate without lamellipodia. Nat Rev Mol Cell
Biol 2008; 9:730-6; PMID:18628785; http://dx.doi.
org/10.1038/nrm2453
15. Burridge K, Wennerberg K. Rho and Rac take center stage. Cell 2004; 116:167-79; PMID:14744429;
http://dx.doi.org/10.1016/S0092-8674(04)00003-0
16. Sander EE, ten Klooster JP, van Delft S, van der
Kammen RA, Collard JG. Rac downregulates Rho
activity: reciprocal balance between both GTPases
determines cellular morphology and migratory behavior. J Cell Biol 1999; 147:1009-22; PMID:10579721;
http://dx.doi.org/10.1083/jcb.147.5.1009
17. Zondag GCM, Evers EE, ten Klooster JP, Janssen L,
van der Kammen RA, Collard JG. Oncogenic Ras
downregulates Rac activity, which leads to increased
Rho activity and epithelial-mesenchymal transition. J
Cell Biol 2000; 149:775-82; PMID:10811819; http://
dx.doi.org/10.1083/jcb.149.4.775
18. Arthur WT, Burridge K. RhoA inactivation by
p190RhoGAP regulates cell spreading and migration
by promoting membrane protrusion and polarity. Mol
Biol Cell 2001; 12:2711-20; PMID:11553710

Small GTPases

19. Spiering D, Hodgson L. Dynamics of the Rho-family
small GTPases in actin regulation and motility. Cell
Adh Migr 2011; 5:170-80; PMID:21178402; http://
dx.doi.org/10.4161/cam.5.2.14403
20. Machacek M, Hodgson L, Welch C, Elliott H, Pertz
O, Nalbant P, et al. Coordination of Rho GTPase
activities during cell protrusion. Nature 2009; 461:99103; PMID:19693013; http://dx.doi.org/10.1038/
nature08242
21. El-Sibai M, Pertz O, Pang H, Yip SC, Lorenz M,
Symons M, et al. RhoA/ROCK-mediated switching
between Cdc42- and Rac1-dependent protrusion in
MTLn3 carcinoma cells. Exp Cell Res 2008; 314:154052; PMID:18316075; http://dx.doi.org/10.1016/j.
yexcr.2008.01.016
22. Narumiya S, Tanji M, Ishizaki T. Rho signaling,
ROCK and mDia1, in transformation, metastasis
and invasion. Cancer Metastasis Rev 2009; 28:65-76;
PMID:19160018; http://dx.doi.org/10.1007/s10555008-9170-7
23. O’Connor KL, Chen M, Towers LN. Integrin α6β4
cooperates with LPA signaling to stimulate Rac through
AKAP-Lbc-mediated RhoA activation. Am J Physiol
Cell Physiol 2012; 302:C605-14; PMID:22049212;
http://dx.doi.org/10.1152/ajpcell.00095.2011
24. Narumiya S, Tanji M, Ishizaki T. Rho signaling,
ROCK and mDia1, in transformation, metastasis
and invasion. Cancer Metastasis Rev 2009; 28:65-76;
PMID:19160018; http://dx.doi.org/10.1007/s10555008-9170-7
25. Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding
proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 2007; 29:35670; PMID:17373658; http://dx.doi.org/10.1002/
bies.20558
26. Chrzanowska-Wodnicka M, Burridge K. Rhostimulated contractility drives the formation of stress
fibers and focal adhesions. J Cell Biol 1996; 133:140315; PMID:8682874; http://dx.doi.org/10.1083/
jcb.133.6.1403

Volume 4 Issue 3

27. Ren XD, Bokoch GM, Traynor-Kaplan A, Jenkins GH,
Anderson RA, Schwartz MA. Physical association of
the small GTPase Rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in Swiss 3T3 cells. Mol Biol
Cell 1996; 7:435-42; PMID:8868471
28. Gilmore AP, Burridge K. Regulation of vinculin binding
to talin and actin by phosphatidyl-inositol-4-5-bisphosphate. Nature 1996; 381:531-5; PMID:8632828;
http://dx.doi.org/10.1038/381531a0
29. Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J 2000; 348:241-55; PMID:10816416;
http://dx.doi.org/10.1042/0264-6021:3480241
30. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts
JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18:86276; PMID:15078817; http://dx.doi.org/10.1101/
gad.1185504
31. Sahai E, Olson MF, Marshall CJ. Cross-talk between
Ras and Rho signalling pathways in transformation
favours proliferation and increased motility. EMBO
J 2001; 20:755-66; PMID:11179220; http://dx.doi.
org/10.1093/emboj/20.4.755
32. O’Connor KL, Shaw LM, Mercurio AM. Release
of cAMP gating by the α6β4 integrin stimulates
lamellae formation and the chemotactic migration of
invasive carcinoma cells. J Cell Biol 1998; 143:174960; PMID:9852165; http://dx.doi.org/10.1083/
jcb.143.6.1749
33. Chen M, Sinha M, Luxon BA, Bresnick AR, O’Connor
KL. Integrin α6β4 controls the expression of genes
associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem
2009; 284:1484-94; PMID:19011242; http://dx.doi.
org/10.1074/jbc.M803997200
34. Reid T, Furuyashiki T, Ishizaki T, Watanabe G,
Watanabe N, Fujisawa K, et al. Rhotekin, a new
putative target for Rho bearing homology to a serine/
threonine kinase, PKN, and rhophilin in the rhobinding domain. J Biol Chem 1996; 271:1355660; PMID:8662891; http://dx.doi.org/10.1074/
jbc.271.23.13556
35. Nagata K, Ito H, Iwamoto I, Morishita R, Asano
T. Interaction of a multi-domain adaptor protein,
vinexin, with a Rho-effector, Rhotekin. Med Mol
Morphol 2009; 42:9-15; PMID:19294487; http://
dx.doi.org/10.1007/s00795-008-0433-8
36. Sudo K, Ito H, Iwamoto I, Morishita R, Asano T,
Nagata K. Identification of a cell polarity-related protein, Lin-7B, as a binding partner for a Rho effector,
Rhotekin, and their possible interaction in neurons.
Neurosci Res 2006; 56:347-55; PMID:16979770;
http://dx.doi.org/10.1016/j.neures.2006.08.003
37. Ito H, Iwamoto I, Morishita R, Nozawa Y, Asano
T, Nagata K. Identification of a PDZ protein, PIST,
as a binding partner for Rho effector Rhotekin:
biochemical and cell-biological characterization of
Rhotekin-PIST interaction. Biochem J 2006; 397:38998; PMID:16646955; http://dx.doi.org/10.1042/
BJ20052015
38. Ying-Tao Z, Yi-Ping G, Lu-Sheng S, Yi-Li W.
Proteomic analysis of differentially expressed proteins
between metastatic and non-metastatic human colorectal carcinoma cell lines. Eur J Gastroenterol Hepatol
2005; 17:725-32; PMID:15947549; http://dx.doi.
org/10.1097/00042737-200507000-00006
39. Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY.
Rho/Rhotekin-mediated NF-kappaB activation confers
resistance to apoptosis. Oncogene 2004; 23:873142; PMID:15480428; http://dx.doi.org/10.1038/
sj.onc.1208106

www.landesbioscience.com

40. Pusapati GV, Eiseler T, Rykx A, Vandoninck S, Derua
R, Waelkens E, et al. Protein Kinase D regulates RhoA
activity via rhotekin phosphorylation. J Biol Chem
2012; 287:9473-83; PMID:22228765
41. Garrett SC, Varney KM, Weber DJ, Bresnick AR.
S100A4, a mediator of metastasis. J Biol Chem
2006; 281:677-80; PMID:16243835; http://dx.doi.
org/10.1074/jbc.R500017200
42. Boye K, Maelandsmo GM. S100A4 and metastasis: a small actor playing many roles. Am J Pathol
2010; 176:528-35; PMID:20019188; http://dx.doi.
org/10.2353/ajpath.2010.090526
43. Helfman DM, Kim EJ, Lukanidin E, Grigorian
M. The metastasis associated protein S100A4: role
in tumour progression and metastasis. Br J Cancer
2005; 92:1955-8; PMID:15900299; http://dx.doi.
org/10.1038/sj.bjc.6602613
44. Saleem M, Adhami VM, Ahmad N, Gupta S, Mukhtar
H. Prognostic significance of metastasis-associated
protein S100A4 (Mts1) in prostate cancer progression
and chemoprevention regimens in an autochthonous
mouse model. Clin Cancer Res 2005; 11:147-53;
PMID:15671539
45. Rudland PS, Platt-Higgins A, Renshaw C, West CR,
Winstanley JH, Robertson L, et al. Prognostic significance of the metastasis-inducing protein S100A4
(p9Ka) in human breast cancer. Cancer Res 2000;
60:1595-603; PMID:10749128
46. Gongoll S, Peters G, Mengel M, Piso P, Klempnauer
J, Kreipe H, et al. Prognostic significance of calcium-binding protein S100A4 in colorectal
cancer. Gastroenterology 2002; 123:1478-84;
PMID:12404222;
http://dx.doi.org/10.1053/
gast.2002.36606
47. Strutz F, Okada H, Lo CW, Danoff T, Carone RL,
Tomaszewski JE, et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol
1995; 130:393-405; PMID:7615639; http://dx.doi.
org/10.1083/jcb.130.2.393
48. Semov A, Moreno MJ, Onichtchenko A, Abulrob A,
Ball M, Ekiel I, et al. Metastasis-associated protein
S100A4 induces angiogenesis through interaction with
Annexin II and accelerated plasmin formation. J Biol
Chem 2005; 280:20833-41; PMID:15788416; http://
dx.doi.org/10.1074/jbc.M412653200
49. Li ZH, Bresnick AR. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res 2006; 66:5173-80;
PMID:16707441; http://dx.doi.org/10.1158/00085472.CAN-05-3087
50. Takenaga K, Nakamura Y, Sakiyama S, Hasegawa
Y, Sato K, Endo H. Binding of pEL98 protein,
an S100-related calcium-binding protein, to nonmuscle tropomyosin. J Cell Biol 1994; 124:75768; PMID:8120097; http://dx.doi.org/10.1083/
jcb.124.5.757
51. Kriajevska M, Fischer-Larsen M, Moertz E, Vorm O,
Tulchinsky E, Grigorian M, et al. Liprin beta 1, a
member of the family of LAR transmembrane tyrosine
phosphatase-interacting proteins, is a new target for the
metastasis-associated protein S100A4 (Mts1). J Biol
Chem 2002; 277:5229-35; PMID:11836260; http://
dx.doi.org/10.1074/jbc.M110976200
52. Dulyaninova NG, Malashkevich VN, Almo SC,
Bresnick AR. Regulation of myosin-IIA assembly
and Mts1 binding by heavy chain phosphorylation.
Biochemistry 2005; 44:6867-76; PMID:15865432;
http://dx.doi.org/10.1021/bi0500776

Small GTPases

53. Tarabykina S, Griffiths TR, Tulchinsky E, Mellon
JK, Bronstein IB, Kriajevska M. Metastasisassociated protein S100A4: spotlight on its
role in cell migration. Curr Cancer Drug Targets
2007; 7:217-28; PMID:17504119; http://dx.doi.
org/10.2174/156800907780618329
54. Chen M, Bresnick AR, O’Connor KL. Coupling
S100A4 to rhotekin alters Rho signaling output
in breast cancer cells. Oncogene 2012; In press;
PMID:22964635.
55. Shih W, Yamada S. Myosin IIA dependent retrograde
flow drives 3D cell migration. Biophys J 2010; 98:L2931; PMID:20409454; http://dx.doi.org/10.1016/j.
bpj.2010.02.028
56. Lim JI, Sabouri-Ghomi M, Machacek M, Waterman
CM, Danuser G. Protrusion and actin assembly
are coupled to the organization of lamellar contractile structures. Exp Cell Res 2010; 316:202741; PMID:20406634; http://dx.doi.org/10.1016/j.
yexcr.2010.04.011
57. Chew TL, Wolf WA, Gallagher PJ, Matsumura F,
Chisholm RL. A fluorescent resonant energy transferbased biosensor reveals transient and regional myosin
light chain kinase activation in lamella and cleavage furrows. J Cell Biol 2002; 156:543-53; PMID:11815633;
http://dx.doi.org/10.1083/jcb.200110161
58. Conklin MW, Eickhoff JC, Riching KM, Pehlke
CA, Eliceiri KW, Provenzano PP, et al. Aligned collagen is a prognostic signature for survival in human
breast carcinoma. Am J Pathol 2011; 178:1221-32;
PMID:21356373;
http://dx.doi.org/10.1016/j.
ajpath.2010.11.076
59. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003; 3:921-30;
PMID:14737122; http://dx.doi.org/10.1038/nrc1231
60. Provenzano PP, Keely PJ. Mechanical signaling through
the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell
Sci 2011; 124:1195-205; PMID:21444750; http://
dx.doi.org/10.1242/jcs.067009
61. Provenzano PP, Inman DR, Eliceiri KW, Trier SM,
Keely PJ. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent
matrix reorganization. Biophys J 2008; 95:5374-84;
PMID:18775961; http://dx.doi.org/10.1529/biophysj.108.133116
62. Provenzano PP, Eliceiri KW, Keely PJ. Shining new
light on 3D cell motility and the metastatic process.
Trends Cell Biol 2009; 19:638-48; PMID:19819146;
http://dx.doi.org/10.1016/j.tcb.2009.08.009
63. Vega FM, Fruhwirth G, Ng T, Ridley AJ. RhoA and
RhoC have distinct roles in migration and invasion by acting through different targets. J Cell Biol
2011; 193:655-65; PMID:21576392; http://dx.doi.
org/10.1083/jcb.201011038
64. Trusolino L, Comoglio PM. Scatter-factor and semaphorin receptors: cell signalling for invasive growth.
Nat Rev Cancer 2002; 2:289-300; PMID:12001990;
http://dx.doi.org/10.1038/nrc779
65. Sahai E, Marshall CJ. Differing modes of tumour
cell invasion have distinct requirements for Rho/
ROCK signalling and extracellular proteolysis. Nat Cell
Biol 2003; 5:711-9; PMID:12844144; http://dx.doi.
org/10.1038/ncb1019

7

